Parkisonism induced by high‐dose cytosine arabinoside
- 1 January 1987
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 2 (3) , 219-222
- https://doi.org/10.1002/mds.870020309
Abstract
We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The durg was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian durgs and fortunately remitted completely within 12 weeks.Keywords
This publication has 9 references indexed in Scilit:
- Cerebellar toxicity following high-dose cytosine arabinoside.Journal of Clinical Oncology, 1985
- Neurologic Complications of Drug TherapyPrimary Care: Clinics in Office Practice, 1984
- High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.Journal of Clinical Oncology, 1984
- Delayed Neurologic Sequelae in Carbon Monoxide IntoxicationArchives of Neurology, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- A Pure Parkinsonian Syndrome Following Acute Carbon Monoxide IntoxicationArchives of Neurology, 1982
- Central nervous system toxicity of high-dose systemic cytosine arabinosideCancer, 1981
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Encephalitis and ParkinsonismArchives of Neurology, 1965